Dear Dr. Roach: I am a 75-year-old man with an elevated A1C level; I was diagnosed with prediabetes. I feel healthy but have struggled to lose weight. I was wondering what your feeling are on using a ...

DEAR DR. ROACH: I am a 75-year-old man with an elevated A1C level; I was diagnosed with prediabetes. I feel healthy but have struggled to lose weight. I was wondering what your feelings are on using a ...

NEW YORK, Dec. 10, 2025 /PRNewswire/ -- Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, announced the publication of a paper in the journal The Lancet ...

A continuous glucose monitor (CGM) can tell you when my glucose spikes, but not that I delayed correcting it because I was in a high-stakes meeting. It can record the number after I under-bolused for ...

A medical device correction has been initiated for 3 million continuous glucose monitors. Certain Freestyle Libre 3 systems may provide incorrect low glucose readings, which can lead to serious health ...

CLEVELAND, Ohio — At University Hospitals, patients are using a wearable device that wirelessly transmits their heart rate and blood pressure to caregivers, even while walking around. UH is among the ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people over the age of 18 with diabetes will ...

The CGM provides real-time glucose readings for 15.5 days. “As a disabled veteran living with Type 2 diabetes, becoming a grandfather has given me a powerful new reason to take charge of my health,” ...

Apple has suffered a major defeat in its long-term legal dispute with the medtech firm Masimo and has been ordered to pay $634 million in damages. As the Daily Journal reports, a federal jury agreed ...

What just happened? Apple has been dealt a blow in its long-running patent battle against Masimo after a court ordered Cupertino to pay the health tech firm $634 million. The decision came on the same ...

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...

In the latest chapter of the long-running legal war between Apple and medical tech company Masimo, a federal jury in California has ordered Apple to pay $634 million in damages. The jury found that ...